Avantor, Inc. (AVTR) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by solid first-quarter 2024 results and operational workflow also looks promising. However, headwinds resulting from the loss of a significant number of customers and forex volatility are major downsides.Over the past year, this Zacks Rank #3 (Hold) stock has rallied 0.9% compared with the 4% rise of the industry and 27.1% growth of the S&P 500.The renowned provider of mission-cr ...

Company Developments - Avantor, Inc. has launched two innovative products, J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease, aimed at improving the gene therapy harvest process, enhancing efficiency, and reducing environmental impact [1][2] - The J.T.Baker Cell Lysis Solution is an eco-friendly alternative to Octoxynol-9, designed to be biodegradable and exhibit low ecotoxicity, aligning with global sustainability goals and REACH regulations [2] - The combination of J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease streamlines the harvest process by effectively removing impurities and reducing aggregation, thus enhancing productivity and maintaining the quality of viral particles [3] Industry Insights - The global gene therapy market is projected to grow from an estimated $10.47 billion to $52.40 billion by 2033, reflecting a compound annual growth rate (CAGR) of 19.6% [4] - Facility expansion for cell and gene therapies is a key driver of market growth, with increased investments in production capacity from in-house facilities and CDMOs [4] Recent Leadership Changes - Avantor appointed Corey Walker as president of Laboratory Solutions, leveraging his industry knowledge and familiarity with the organization to lead the business effectively [5] Stock Performance - Avantor's shares have declined by 9% year-to-date, contrasting with a 3.6% rise in the industry and a 15% increase in the S&P 500 during the same period [6]

Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at ScaleRADNOR, Pa., July 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease."These products ...

RADNOR, Pa., June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results. To hear a live audio webcast of the session, visit Events & Presentations in the Investo ...

RADNOR, Pa. , June 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Corey Walker has rejoined the company as President of Avantor's Laboratory Solutions business, reporting to CEO Michael Stubblefield.© 2017 - www.chorusphotography.com"Corey's deep knowledge of our end markets and industry, coupled with his familiarity with our organization and ...

Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of scheduleRADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today. The report highlights the meaningful progress Avantor made in 2023 against four Science for Goodness sustainability pillars: People & Culture, Innovation & Environment, Comm ...

Core Points - Avantor, Inc. is a leading global provider of mission-critical products and services in the life sciences and advanced technologies sectors [1][2] - The company will have its President and CEO, Michael Stubblefield, participate in a fireside chat at Bernstein's 40th Annual Strategic Decisions Conference on May 30, 2024 [1] - The event will be accessible via a live audio webcast, with a replay available for 30 days [1] Company Overview - Avantor is a Fortune 500 company that collaborates closely with customers throughout the scientific journey to facilitate breakthroughs in medicine, healthcare, and technology [2] - The company's portfolio is utilized in nearly every stage of significant research, development, and production activities across over 300,000 customer locations in 180 countries [2] - Avantor maintains a presence on various social media platforms including LinkedIn, Twitter, and Facebook [2]

Group 1 - Avantor, Inc. is a leading global provider of mission-critical products and services to the life sciences and advanced technologies industries [2] - The company will have its President and CEO, Michael Stubblefield, participate in a fireside chat at the BofA Securities 2024 Health Care Conference on May 14, 2024 [1] - The event will be available for live audio webcast, with a replay accessible for 30 days [1] Group 2 - Avantor operates in over 300,000 customer locations across 180 countries, emphasizing its extensive reach in the life sciences sector [2] - The company is recognized as a Fortune 500 entity, highlighting its significant position in the industry [2] - Avantor's portfolio supports critical research, development, and production activities, contributing to advancements in medicine, healthcare, and technology [2]

Avantor, Inc. (AVTR) reported first-quarter 2024 adjusted earnings per share (EPS) of 22 cents, down 24.1% year over year. However, the bottom line surpassed the Zacks Consensus Estimate by 10%.GAAP EPS for the quarter was 9 cents, down 50% year over year.Revenue DetailsRevenues grossed $1.68 billion in the reported quarter, down 5.6% year over year. However, the metric was in line with the Zacks Consensus Estimate.Avantor's foreign currency translation reflects a 0.7% favorable impact in the reported quart ...

Avantor Inc. (NYSE:AVTR) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and Chief Executive Officer Brent Jones – Executive Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Dan Leonard – UBS Dan Brennan – TD Cowen Luke Sergott – Barclays Vijay Kumar – Evercore ISI Jack Meehan – Nephron Research Doug Schenkel – Wolfe Research Rachel Vatn ...